Application Know How Clause Samples

Application Know How. Upon request by ▇▇▇▇▇▇▇, SSI shall transfer to Evaxion all Application Know How. SSI shall confirm in writing to Evaxion that such transfer is complete after it has delivered to Evaxion all of such Application Know How. SSI shall reasonably assist Evaxion, at Evaxion’s request, in the use and understanding of the Application Know How and Licensed Adjuvant, including providing responses to follow-up or ad-hoc queries via email or telephone, provided, however, that Personnel designated by Evaxion to receive such advice must be fully trained and experienced in the formulation of adjuvants for vaccine use in humans. 5. PROVISION OF LICENSED ADJUVANT 5.1 Supply of Licensed Adjuvant for Phase 3 Clinical Trials & commercialisation 5.1.1 Evaxion and the Commercial Supplier shall negotiate terms and conditions for the supply by the Commercial Supplier of Licensed Adjuvant as required by Evaxion for Phase 3 Clinical Trials and subsequent commercialization of the Vaccine. In the event that Evaxion and the Commercial Supplier are not able to agree to terms and conditions of such supply agreement acceptable to both parties before 20 December 2024 Evaxion shall be entitled to terminate this Agreement by a ten (10) days written notice to SSI. 5.1.2 In the event that the agreement between SSI and the Commercial Supplier and manufacturer of the Licensed Adjuvant is terminated, SSI will inform Evaxion hereof without unreasonable delay and in good faith work with Evaxion to try to identify a new manufacturer and supplier of the Licensed Adjuvant to meet the needs of Evaxion.